BraggeP., SynnotA., MaasA.I., MenonD.K., CooperD.J., RosenfeldJ.V., and GruenR.L. (2016). A state-of-the-science overview of randomized controlled trials evaluating acute management of moderate-to-severe traumatic brain injury. J. Neurotrauma, 33, 1461–1478.
2.
BurkeM.J., FralickM., NejatbakhshN., TartagliaM.C., and TatorC.H. (2015). In search of evidence-based treatment for concussion: characteristics of current clinical trials. Brain Inj. 29, 300–305.
3.
MarklundN., BakshiA., CastelbuonoD.J., ConteV., and McIntoshT. (2006). Evaluation of pharmacological treatment strategies in traumatic brain injury. Curr. Pharm. Des. 12, 1645–1680.
4.
AgostonD.V., RislingM., and BellanderB.-M. (2012). Bench-to-bedside and bedside back to the bench; coordinating clinical and experimental traumatic brain injury studies. Front. Neurol. 3, 1–5.
5.
KochanekP.M., BramlettH.M., DixonC.E., ShearD.A., DietrichW.D., SchmidK.E., MondelloS., WangK.K.W., HayesR.L., PovlishockJ.T., and TortellaF.C. (2016). Approach to modeling, therapy evaluation, drug selection, and biomarker assessments for a multicenter pre-clinical drug screening consortium for acute therapies in severe traumatic brain injury: Operation Brain Trauma Therapy. J. Neurotrauma, 33, 513–522.
6.
LoaneD.J., and FadenA.I. (2010). Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol. Sci. 31, 596–604.
7.
PageM.J., HigginsJ.P., ClaytonG., SterneJ.A.C., HrobjartssonA., and SavovicJ. (2016). Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies. PLoS One, 11, e0159267.
8.
ButtonK.S., IoannidisJ.P.A., MokryszC., NosekB.A., FlintJ., RobinsonE.S.J., and MunafoM.R. (2013). Power failure: why small sample size undermines the reliability of neuroscience. Nat. Rev. Neurosci. 14, 365–376.
9.
EggerM., Davey-SmithG., SchneiderM., and MinderC. (1997). Bias in meta-analysis detected by a simple, graphical test. Brit. Med. J. 315, 629–634.
10.
HawkyrlukG.W.J., and BullockM.R. (2015). Design of acute neuroprotection studies, in: Handbook of Clinical Neurology, Traumatic Brain Injury, Part II, Vol. 128, J. Grafman, and A.M. Salazar (eds). ScienceDirect, pps. 761–778.
11.
MenonD.K. (2009). Unique challenges in clinical trials in traumatic brain injury. Crit. Care Med. 37, S129–S135.
12.
StocchettiN., TacconeF.S., CiterioG., PepeP.E., Le RouxP.D., OddoM., PoldermanK.H., StevensR.D., BarsanW., MaasA.I., MeyfroidtG., BellM.J., SilbergleitR., VespaP.M., FadenA.I., HelbokR., TishermanS., ZanierE.R., ValenzuelaT., WendonJ., MenonD.K., and VincentJ.L. (2015). Neuroprotection in acute brain injury: an up- to-date review. Crit. Care, 19, 186.
FergusonA.R., NielsonJ.L., CraginM.H., BandrowskiA., and MartoneM.E. (2014). Big data from small data: data-sharing in the ‘long tail’ of neuroscience. Nat. Neurosci. 17, 1442–1448.
